Low density Lipoprotein cholesterol target: Changing goal posts
Elevated low density lipoprotein cholesterol (LDL) has been identified as one of the strongest correctable risk factors for cardiovascular disease in patients with diabetes. The reduction in cardiovascular events with pharmacological therapy aimed at LDL lowering is well documented in both primary p...
Main Authors: | Ganapathi Bantwal, Belinda George |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=8;spage=233;epage=235;aulast=Bantwal |
Similar Items
-
Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
by: Chih-Sheng Chu, et al.
Published: (2020-07-01) -
Statin Discontinuation after Achieving a Target Low Density Lipoprotein Cholesterol Level in Type 2 Diabetic Patients without Cardiovascular Disease: A Randomized Controlled Study
by: Seung-Hwan Lee, et al.
Published: (2014-02-01) -
Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020-01-01) -
Warning Against Low-Density Lipoprotein Oxidation in Users of Oral Combined Contraceptives
by: Marcelo Chiara Bertolami -
Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
by: Sigdel Manoj, et al.
Published: (2012-11-01)